HemoSonics LLC
HemoSonics is dedicated to transforming coagulation management by providing comprehensive, timely point-of-care testing solutions. Their mission is to improve patient care through innovative viscoelastic testing technology, enabling clinicians to make rapid, informed decisions in critical settings such as surgery, trauma, and transplantation.
Industries
Nr. of Employees
small (1-50)
HemoSonics LLC
4020 Stirrup Creek Dr, Suite 105 Durham, NC 27703-8970 USA
Patents
Products
Cartridge-based whole blood hemostasis analyzer (ultrasound sonorheometry)
An enclosed automated analyzer that runs sealed disposable cartridges to measure whole-blood viscoelastic parameters with graphical outputs for rapid clinical interpretation.
External quality control kits (lyophilized levels)
Two-level external biological control kits provided as lyophilized materials for external quality verification and proficiency testing.
Consumable accessories (cleaning cartridges, printers)
Support consumables and accessories for analyzer maintenance and result output including cleaning cartridges and printers.
Cartridge-based whole blood hemostasis analyzer (ultrasound sonorheometry)
An enclosed automated analyzer that runs sealed disposable cartridges to measure whole-blood viscoelastic parameters with graphical outputs for rapid clinical interpretation.
External quality control kits (lyophilized levels)
Two-level external biological control kits provided as lyophilized materials for external quality verification and proficiency testing.
Consumable accessories (cleaning cartridges, printers)
Support consumables and accessories for analyzer maintenance and result output including cleaning cartridges and printers.
Services
Periodic EQA program for viscoelastic hemostasis assays to benchmark laboratory performance across peer groups.
Product support, user training materials and technical assistance for device operation, QC, and interpretation workflows.
Desktop software enabling live and historical remote access to analyzer results on a networked system.
Periodic EQA program for viscoelastic hemostasis assays to benchmark laboratory performance across peer groups.
Product support, user training materials and technical assistance for device operation, QC, and interpretation workflows.
Desktop software enabling live and historical remote access to analyzer results on a networked system.
Expertise Areas
- Viscoelastic hemostasis testing
- Point-of-care coagulation diagnostics
- Clinical validation and comparative method studies
- Laboratory integration and quality management (IQCP, CAP/CLIA)
Key Technologies
- Ultrasound-based sonorheometry (resonance sonorheometry)
- Cartridge-based multi-channel viscoelastic assays
- Point-of-care viscoelastic hemostatic assays (VHA)
- Remote desktop result viewer software
News & Updates
Discover the future of thrombosis and hemostasis research with a network of leading experts, scheduled for June 21-25, 2025 in Washington, D.C.
Engage with world-class speakers and technologies advancing medical innovation, scheduled for July 15-17, 2025 in National Harbor, MD.
HemoSonics Wins Best Medical Device Company in Triangle Business Journal’s 2025 Life Sciences Awards
HemoSonics was recognized as the Best Medical Device Company in the 2025 Life Sciences Awards by Triangle Business Journal.
HemoSonics was recognized as one of the fastest-growing companies in North America in 2024 by Deloitte.
The Quantra Hemostasis System received a special mention in TIME's 2024 Best Inventions List.
HemoSonics received a prize from the NIH to expand the use of the Quantra Hemostasis System to help prevent maternal deaths.
Discover the future of thrombosis and hemostasis research with a network of leading experts, scheduled for June 21-25, 2025 in Washington, D.C.
Engage with world-class speakers and technologies advancing medical innovation, scheduled for July 15-17, 2025 in National Harbor, MD.
HemoSonics Wins Best Medical Device Company in Triangle Business Journal’s 2025 Life Sciences Awards
HemoSonics was recognized as the Best Medical Device Company in the 2025 Life Sciences Awards by Triangle Business Journal.
HemoSonics was recognized as one of the fastest-growing companies in North America in 2024 by Deloitte.
The Quantra Hemostasis System received a special mention in TIME's 2024 Best Inventions List.
HemoSonics received a prize from the NIH to expand the use of the Quantra Hemostasis System to help prevent maternal deaths.